ANXA2 and prostate carcinoma: However, reduced or lost expression of annexin 2 has been noticed in prostate carcinoma (Liu et al, 2003a) and osteosarcoma (Gillette et al, 2004) and has been related to aggressive behaviour and metastatic potential.